Wang et al. published two reviews discussing TRK inhibitors in solid and CNS tumors but did not emphasize HGGs [58,59], while Lang et al. exclusively focused on pediatric CNS tumors [60]. Here, NTRK1 is linked to central nervous system neoplasm.